The Academy of Diagnostics & Laboratory Medicine is pleased to announce the winners of the 2024 Distinguished Abstracts Awards. A group of Fellows selected these 29 abstracts for their scientific excellence from a pool of more than 775 abstracts accepted for ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo).
Winning abstracts will display the Academy blue ribbon during the ADLM 2024 poster sessions.
A-086 – Bradley Collier, Burlington, NC
Clinical Performance of a Plasma ATN Panel for Assessment of Alzheimer’s Disease
A-157 – Tushar Sehgal, Delhi, India
Utility of kaolin TEG and rapid TEG to predict coagulopathy in severe traumatic brain injury
A-167 – Brody Foy, Seattle, WA
Hematologic setpoints are a deep physiologic phenotype which enable personalized blood count reference intervals
A-210 Thando Gcingca, Bethesda, MD
Ldl-c to non-hdl-c ratio method: a simple way to determine bias for ldl-c methods on hypertriglyceridemic samples.
A-211 – Benjamin Andress
Lipids in the Afternoon: Effect on LDL-C, Triglycerides, and Collection Time When Removing Fasting Requirements for Lipid Panels
A-227 – Heather Melson, Salt Lake City, UT
One Step Toward Implementation of Advanced Lipoprotein Testing in Children: A Pilot Study on Pediatric Reference Ranges
A-268 – Tina Bui-Bullock, Saint Louis, MO
Comparison of the Elecsys® HCV Duo Assay to Standard of Care Algorithmic Testing
A-288 – Soraya de Andrade, São Paulo, Brazil
Active Surveillance Cultures: Frequency of Microorganisms and Phenotypic Resistance Profile From Brazilian Public Hospitals After COVID-19 Pandemic Peak
A-310 – Eros Qama, Bronx, NY
Neurodevelopmental disorders and hyperlipidemia in HIV-exposed uninfected children in the Bronx, New York
A-320 – Kuldeep Dhillon, Richmond, CA
Determination of Guanidinoacetate Methytransferase Enzyme Biomarkers in Newborn Cried Blood Spot by Tandem Mass Spectrometry-A Two Tier Approach
B-052 – Danting Liu, Rochester, MN
Celiac Disease Risk Assessment of HLA-DQ Typing in IgA Deficient Patients
B-060 – Tomas De Haro, Spain
Prevalence of CCD and profilins antibodies in a seasonal allergy study
B-102 – Fay Stewart, Birmingham, United Kingdom
The Impact of Protein / Protein Interactions on Serum Free Light Chain Assay Calibration
B-116 – Laura Puigví, Vilafranca del Penedès, Spain
Cost Estimation of Laboratory Test Overuse in 14 Ordered Parameters: Experience From 6 hospitals and 65 Primary Care Centers
B-123 – Hunter Miller, Louisville, KY
Prediction of Opioid Use Duration in Post-Surgical Orthopedic Patients Using CYP2D6 Inhibitor Index and Routine Laboratory Markers
B-137 – Raj Gopalan, Durham, NC
Sepsis risk prediction using machine learning (ML) and routine blood markers up to 1 week before emergency admission
B-149 – Yifei Yang, Rochester, MN
Diverse glycosylation of circulating alpha fetoprotein in chronic liver diseases profiled by intact mass high resolution mass spectrometry
B-153 – Rong Yi, Vancouver, Canada
Improving Accuracy of IgG subclasses Quantitation in Serum Using Liquid Chromatography - Tandem Mass Spectrometry (LC-MS/MS) on SCIEX 7500
B-200 – Tonya Jagneaux, Baton Rouge, LA
Expediting Identification of Occult Sepsis with a Novel Diagnostic for Patients Presenting to the ED with Possible Infection
B-232 – Michelle Dina, Rochester, MN
One Year Post-Implementation Experience Using a Custom Designed DNA Contamination Detection Module for a Clinical Myeloid Neoplasm Next Generation Sequencing Assay
B-240 – Matthew Baker, Glasgow, United Kingdom
Multi-omic blood test for early detection of cancer and pre-cancer
B-247 – Ievgen Motorykin, San Juan Capistra, CA
A Missing Peptide Link: A Case Study Involving Detection of an Unusual IGF-1 Protein Form Using High-Resolution Mass Spectrometry
B-251 – Manan Vij, New York, NY
Comprehensive Proteomics Analysis Reveals an Exosomal Biomarker Signature Useful for Detection of Non-Small Cell Lung Cancer
B-255 – Zoi Sychev, Minneapolis, MN
Identification of the protein expression of Androgen Receptor variants using Targeted proteomics in clinical Castration Resistant Prostate Cancer models
B-288 – Mellia Bennett, Calgary, Canada
Turning False Positive Screening into True Positive Results
B-304 – Amy Theriault, Birmingham, AL
Development of free valproic acid estimating equations for adult epileptic patients
B-308 – Brendan Manning, Waltham, MA
Analytical and clinical performance of a novel ovarian cancer screening test in asymptomatic women
B-318 – Álvaro González, Pamplona, Spain
Serum PSA in Extracellular Vesicles: Immunoreactivity to Commercial Kits and Elimination Kinetics
B-337 – Cristina Agulló, Salamanca, Spain
Mass Spectrometry to evaluate treatment response in patients with Multiple Myeloma. A comparative study versus Immunofixation.
Fellows of the Academy use the designation of FADLM. This designation is equivalent to FACB and FAACC, the previous designations used by fellows of the National Academy of Clinical Biochemistry and AACC Academy. Those groups were rebranded as Academy of Diagnostics & Laboratory Medicine in 2023.
